Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Antithrombin and its inherited deficiencies

¹Department of Haematology, University of Cambridge, MRC Centre, UK.

|March 1, 1994

Summary

Human antithrombin, a key protein regulating blood clotting, shows increased activity with heparin. Deficiencies in antithrombin (AT) increase thrombosis risk, with Type I and II linked to DNA mutations and specific protein alterations, respectively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Histological validation of a type 1 diabetes clinical diagnostic model for classification of diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2020

Same author

Factor X and its deficiency states.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Same author

Laboratory monitoring of haemostasis.

Anaesthesia·2014

Same author

Genetic testing in bleeding disorders.

Haemophilia : the official journal of the World Federation of Hemophilia·2014

Same author

Recurrent pregnancy loss and thrombophilia.

The Ceylon medical journal·2014

Same author

Pollen pool heterogeneity in jack pine (Pinus banksiana Lamb.): a problem for estimating outcrossing rates?

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013

Area of Science:

Biochemistry
Molecular Biology
Hematology

Background:

Human antithrombin (AT) is the primary plasma inhibitor of coagulation serine proteases, crucial for regulating thrombin activity.
AT belongs to the serpin superfamily and exhibits enhanced inhibitory function in the presence of heparin.
Two key domains in AT are the reactive site domain and the heparin-binding domain.

Purpose of the Study:

To investigate the structure-function relationship of human antithrombin.
To understand the genetic basis and clinical implications of antithrombin deficiency.
To differentiate between Type I and Type II antithrombin deficiencies based on molecular mechanisms.

Main Methods:

Gene cloning and nucleotide sequencing of human antithrombin.
Functional and immunological assays for antithrombin activity.
Analysis of DNA mutations and protein structure in deficiency states.

Main Results:

Antithrombin deficiency affects approximately 1:300 individuals and up to 5% of thrombotic disease patients.
Type I deficiency results from diverse DNA mutations, while Type II is characterized by missense mutations.
Thrombosis risk in Type II deficiency correlates with mutation location, with reactive site mutations posing a higher risk than heparin-binding domain mutations.

Conclusions:

Antithrombin deficiency, classified into Types I and II, significantly elevates the risk of thromboembolic disease.
Genetic mutations in the antithrombin gene underlie these deficiencies, impacting protein function and clinical outcomes.
Understanding mutation location is critical for assessing thrombosis risk in Type II antithrombin deficiency.

Related Experiment Videos